2篇
您的检索式：作者名="Congwei Qin"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | High performance octahedral PtNi/C catalysts investigated from rotating disk electrode to membrane electrode assembly显示文摘Octahedral PtNi/C catalysts have demonstrated superior catalytic performance in oxyge n reduction reacti on (ORR) over commercial Pt/C with rotating disk electrode (RDE). However, it is not trivial to translate such promising results to real-world membrane-electrode assembly (MEA). In this work, we have synthesized octahedral PtNi/C catalysts using poly(diallyldimethylammonium chloride)(PDDA) as a capping age nt and in vestigated their performance from RDE to MEA. In RDE, mass activity and specific activity of the optimized octahedral PtNi/C catalyst for oxygen reduction reaction (ORR) are nearly 19 and 28 times high of the state-of-the-art commercial Pt/C, respectively. At MEA level, the octahedral PtNi/C catalyst exhibits excelle nt power generation performa nee and durability paired with commercial Pt/C ano de. Its cell voltage at 1,000mA·cm^-2 reaches 0.712 V, and maximum power density is 881.6 mW·cm^-2 and its performance attenuation is also less, around 11.8% and 7% under galvanostatic condition of 1,000 mA·cm^-2 for 100 h. Such results are investiaged by thermodynamic analysis and fundametal performance modeling, which indicate the single cell performance can be further improved by reducing the size of PtNi/C catalyst agglomerates. Such encouraging results have demonstrated the feasibility to convey the superior performance of octahedral PtNi/C from RDE to MEA. | Bing Li Jue Wang Xin Gao Congwei Qin Daijun Yang Hong Lv Qiangfeng Xiao Cunman Zhang | 2019 | Nano Research2019，12，2： | 3 |
| 2 | SMC1A served as a potential therapeutic target to regulate malignant phenotypes of cervical cancer显示文摘Introduction:Structural maintenance of chromosome 1A(SMC1A)is a crucial compound of the cohesin complex.It has been reported to regulate the epithelial-mesenchymal transition(EMT)process in multiple cancers.Objectives:The present study aims to further clarify the role of SMC1A in cervical cancer.Methods:We analyzed data from four datasets and confirmed that SMC1A showed high expression in cervical cancer samples and was related to poor prognosis of patients with cervical cancer.Cell proliferation of SiHa and C-33A with knockdown of SMC1A was assessed using CCK-8 and colony formation assay.The migration and invasion were estimated by wound healing assay and Transwell assay separately.The effect of SMC1A on the chemosensitivity of cisplatin and paclitaxel in cervical cancer cells was detected by flow cytometry assay.Results:Results of the immunohistochemistry(IHC)assay confirmed that the expression of SMC1A was increased in tumor tissues.The cell viability was remarkably suppressed in SiHa and C-33A by knocking down the expression of SMC1A.The increase of E-cadherin expression and decrease of N-cadherin and Snail expression verified that inhibition of SMC1A suppressed the EMT process of cervical cancer cells.Further,cell migration,and invasion were significantly repressed by the absence of SMC1A.Cisplatin and paclitaxel are effective chemotherapeutic agents used in the treatment of cervical cancer.Silencing of SMC1A remarkably promoted the apoptosis induced by cisplatin and paclitaxel,revealing that the chemotherapy resistance to cisplatin and paclitaxel in cervical cancer could reduce by knocking down SMC1A.Further,metastasis associated with colon cancer 1(MACC1)was identified as the downstream factor of SMC1A.Its upregulation reversed the proliferation and the EMT process induced by SMC1A silencing.Conclusion:Therefore,our study concluded that SMC1A serves as a therapeutic molecular target to regulate the malignant phenotypes of cervical cancer. | WEILAN LIU XIAOYAN DUAN KAIYUN QIN YAN JIANG CAIFU ZHAO CONGWEI DAI | 2023 | BIOCELL2023，47，11： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员